These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 25643772)

  • 1. [Human leukocyte antigen-G (HLA)-G as a biomarker in cancer].
    Porras-Dorantes Á; García-Ortiz JE
    Gac Med Mex; 2014 Dec; 150 Suppl 2():138-9. PubMed ID: 25643772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular pathways: human leukocyte antigen G (HLA-G).
    Curigliano G; Criscitiello C; Gelao L; Goldhirsch A
    Clin Cancer Res; 2013 Oct; 19(20):5564-71. PubMed ID: 23897901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human leukocyte antigen-G expression and polymorphisms promote cancer development and guide cancer diagnosis/treatment.
    Zhang Y; Yu S; Han Y; Wang Y; Sun Y
    Oncol Lett; 2018 Jan; 15(1):699-709. PubMed ID: 29399142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-G Molecules in Autoimmune Diseases and Infections.
    Rizzo R; Bortolotti D; Bolzani S; Fainardi E
    Front Immunol; 2014; 5():592. PubMed ID: 25477881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunosuppressive molecule HLA-G and its clinical implications.
    González A; Rebmann V; LeMaoult J; Horn PA; Carosella ED; Alegre E
    Crit Rev Clin Lab Sci; 2012; 49(3):63-84. PubMed ID: 22537084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human leukocyte antigen-G (HLA-G) as a marker for diagnosis, prognosis and tumor immune escape in human malignancies.
    Yie SM; Hu Z
    Histol Histopathol; 2011 Mar; 26(3):409-20. PubMed ID: 21210353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biology of the immunomodulatory molecule HLA-G in human liver diseases.
    Amiot L; Vu N; Samson M
    J Hepatol; 2015 Jun; 62(6):1430-7. PubMed ID: 25772038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Leukocyte Antigen (HLA) and Immune Regulation: How Do Classical and Non-Classical HLA Alleles Modulate Immune Response to Human Immunodeficiency Virus and Hepatitis C Virus Infections?
    Crux NB; Elahi S
    Front Immunol; 2017; 8():832. PubMed ID: 28769934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human leukocyte antigen G expression in breast cancer: role in immunosuppression.
    Elliott RL; Jiang XP; Phillips JT; Barnett BG; Head JF
    Cancer Biother Radiopharm; 2011 Apr; 26(2):153-7. PubMed ID: 21510769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-G-dependent suppressor cells: Diverse by nature, function, and significance.
    Carosella ED; HoWangYin KY; Favier B; LeMaoult J
    Hum Immunol; 2008 Nov; 69(11):700-7. PubMed ID: 18817832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune modulation of HLA-G dimer in maternal-fetal interface.
    Kuroki K; Maenaka K
    Eur J Immunol; 2007 Jul; 37(7):1727-9. PubMed ID: 17587197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of human leukocyte antigen-G expression in the diagnosis of human cancer.
    Shih IeM
    Hum Immunol; 2007 Apr; 68(4):272-6. PubMed ID: 17400063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble monomers, dimers and HLA-G-expressing extracellular vesicles: the three dimensions of structural complexity to use HLA-G as a clinical biomarker.
    Nardi Fda S; König L; Wagner B; Giebel B; Santos Manvailer LF; Rebmann V
    HLA; 2016 Sep; 88(3):77-86. PubMed ID: 27440734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-classical MHC-I human leukocyte antigen (HLA-G) in hepatotropic viral infections and in hepatocellular carcinoma.
    Catamo E; Zupin L; Crovella S; Celsi F; Segat L
    Hum Immunol; 2014 Dec; 75(12):1225-31. PubMed ID: 25318079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of human leukocyte antigen-G (HLA-G) expression and disease progression in epithelial ovarian cancer.
    Jung YW; Kim YT; Kim SW; Kim S; Kim JH; Cho NH; Kim JW
    Reprod Sci; 2009 Nov; 16(11):1103-11. PubMed ID: 19692629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The non-classical antigens of HLA-G and HLA-E as diagnostic and prognostic biomarkers and as therapeutic targets in transplantation and tumors.
    Seliger B
    Clin Transpl; 2013; ():465-72. PubMed ID: 25095542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered pattern of major histocompatibility complex expression in renal carcinoma: tumor-specific expression of the nonclassical human leukocyte antigen-G molecule is restricted to clear cell carcinoma while up-regulation of other major histocompatibility complex antigens is primarily distributed in all subtypes of renal carcinoma.
    Ibrahim EC; Allory Y; Commo F; Gattegno B; Callard P; Paul P
    Am J Pathol; 2003 Feb; 162(2):501-8. PubMed ID: 12547708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No expression of human leukocyte antigen G (HLA-G) in colorectal cancer cells.
    Leelawat K; Engprasert S; Pongchai-rerk U; Tuchinda S; Suthipintawong C; Leardkamolkarn V
    J Med Assoc Thai; 2004 Jul; 87(7):816-8. PubMed ID: 15521238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the HLA-G gene and molecule on the clinical expression of rheumatologic diseases.
    Brenol CV; Veit TD; Chies JA; Xavier RM
    Rev Bras Reumatol; 2012; 52(1):82-91. PubMed ID: 22286648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Importance of HLA-G in therapy of cancer].
    Zidi I; Bartegi A
    Therapie; 2008; 63(4):327-32. PubMed ID: 18937912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.